Literature DB >> 16521644

Single therapeutic catheterization for treatment of native coarctation of aorta and large patent ductus arteriosus using a covered stent.

Snehal Kulkarni1, J Vimala, Ramesh Parmar.   

Abstract

A 20-year-old girl was diagnosed to have severe coarctation of the aorta, large patent ductus arteriosus and severe pulmonary artery hypertension. She underwent single therapeutic catheterization for the treatment of native coarctation of aorta and closure of ductus arteriosus using 39 mm long Cheatham-Platinum covered stent. The procedure was done successfully under local anesthesia without any complication. This appears to be a safe strategy while dealing with an adolescent or an adult with this combination of lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16521644

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  5 in total

1.  Single therapeutic catheterization for treatment of late diagnosed native coarctation of aorta using a covered stent.

Authors:  Alper V Ural; Ilker Murat Caglar; Fatma Nihan Turhan Caglar; Serkan Ciftci; Osman Karakaya
Journal:  J Clin Diagn Res       Date:  2014-03-15

2.  Usefulness of endovascular stent-graft for combination with a strict aort coarctation and patent ductus arteriosus for an adult patient: a case report.

Authors:  Mustafa Kemal Batur; Mevlut Koç; Ilkut Ozer; Gulcan Abali
Journal:  Cases J       Date:  2009-09-15

3.  Different transcatheter strategies for aortic coarctation associated with patent ductus arteriosus.

Authors:  Anil Kumar Singhi; Kothandam Sivakumar
Journal:  Indian Heart J       Date:  2012-07-02

4.  Use of covered stents in simultaneous management of coarctation of the aorta and patent ductus arteriosus.

Authors:  Emine Hekim Yılmaz; Mustafa Orhan Bulut; Mehmet Küçük; İlker Kemal Yücel; Abdullah Erdem; Ahmet Çelebi
Journal:  Anatol J Cardiol       Date:  2018-03-21       Impact factor: 1.596

5.  Use of covered stents to treat coarctation of the aorta.

Authors:  Shakeel Ahmed Qureshi
Journal:  Korean Circ J       Date:  2009-07-28       Impact factor: 3.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.